参考文献/References:
[1] De Melo Reis RA, Cabral-Da-Silva Me, De Mello FG, et al.Müller glia factors induce survival and neuritogenesis of peripheral and central neurons[J]. Brain Res, 2008, 1205:1-11. DOI:10.1016/j.brainres.2008.02.035.
[2] Kubrusly RC, Panizzutti R, Gardino PF, et al. Expression of functional dopaminergic phenotype in purified cultured muller cells from vertebrate retina[J]. Neurochem Int, 2008, 53(3/4):63-70. DOI:10.1016/j.neuint.2008.05.002.
[3] Semkova I, Huemmeke M, Ho MS, et al. Retinal localization of the glutamate receptor GluR2 and GluR2-regulating proteins in diabetic rats[J]. Exp Eye Res, 2010, 90(2):244-253. DOI:10.1016/j.exer.2009.10.012.
[4] Gu L, Xu H, Wang F, et al. Erythropoietin exerts a neuroprotective function against glutamate neurotoxicity in experimental diabetic retina[J]. Invest Ophthalmol Vis Sci, 2014, 55(12):8208-8222. DOI:10.1167/iovs.14-14435.
[5] Belforte NA, Moreno MC, De Zavalía N, et al. Melatonin:a novel neuroprotectant for the treatment of glaucoma[J]. J Pineal Res, 2010, 48(4):353-364. DOI:10.1111/j.1600-079X.2010.00762.x.
[6] 王中峰, 杨雄里. 谷氨酸受体在实验性青光眼视网膜细胞损伤中的作用[J]. 生理学报, 2016, 68(4):483-491. Wang ZF, Yang XL. Glutamate receptor-mediated retinal neuronal injury in experimental glaucoma[J]. Acta Physiol Sin, 2016, 68(4):483-491.
[7] Santiago AR, Hughes JM, Kamphuis W, et al. Diabetes changes ionotropic glutamate receptor subunit expression level in the human retina[J]. Brain Res, 2008, 1198:153-159. DOI:10.1016/j.brainres.2007.12.030.
[8] Fu S, Dong S, Zhu M, et al. Müller Glia are a major cellular source of survival signals for retinal neurons in diabetes[J]. Diabetes, 2015, 64(10):3554-3563. DOI:10.2337/db15-0180.
[9] Akopian A, Kumar S, Ramakrishnan H, et al. Amacrine cells coupled to ganglion cells via gap junctions are highly vulnerable in glaucomatous mouse retinas[J/OL]. J Comp Neurol, 2016[2017-06-20]. http://onlinelibrary.wiley.com/doi/10.1002/cne.24074/abstract.[Epublished online ahead of print July 25, 2016]. DOI:10. 1002/cne.24074.
[10] Sanchez-Chavez G, Velazquez-Flores MA, Ruiz ER, et al. Glycine receptor subunits expression in the developing rat retina[J]. Neuro-chem Int, 2017,108:177-182. DOI:10.1016/j.neuint.2017.03.013.
[11] Zhou X, Pardue MT, Iuvone PM, et al. Dopamine signaling and myopia development:What are the key challenges[J/OL]. Prog Retin Eye Res, 2017[2017-06-20]. https://linkinghub.elsevier.com/retrieve/pii/S1350-9462(17)30010-1.DOI:10.1016/j.preteyeres.2017.06.003.
[12] Yang JW, Xu YC, Sun L, et al. 5-hydroxytryptamine level and 5-HT2A receptor mRNA expression in the guinea pigs eyes with spectacle lens-induced myopia[J]. Int J Ophthalmol, 2010, 3(4):299-303. DOI:10.3980/j.issn.2222-3959.2010.04.05.
[13] Wang WF, Ishiwata K, Kiyosawa M, et al. Investigation of the use of positron emission tomography for neuroreceptor imaging in rabbit eyes[J]. Ophthalmic Res, 2004, 36(5):255-263. DOI:10.1159/000081205.
[14] Malmfors T. Evidence of adrenergic neurons with synaptic terminals in the retina of rats demonstrated with fluorescence and electron microscopy[J]. Acta Physiol Scand, 1963, 58(1):99-100. DOI:10.1111/j.1748-1716.1963.tb02632.x.
[15] Nickla DL, Totonelly K, Dhillon B. Dopaminergic agonists that result in ocular growth inhibition also elicit transient increases in choroidal thickness in chicks[J]. Exp Eye Res, 2010, 91(5):715-720. DOI:10.1016/j.exer.2010.08.021.
[16] Huang F, Yan T, Shi F, et al. Activation of dopamine D2 receptor is critical for the development of form-deprivation myopia in the C57BL/6 mouse[J]. Invest Ophthalmol Vis Sci, 2014, 55(9):5537-5544. DOI:10.1167/iovs.13-13211.
[17] Ward AH, Siegwart JT, Frost MR, et al. Intravitreally-administered dopamine D2-like (and D4), but not D1-like, receptor agonists reduce form-deprivation myopia in tree shrews[J/OL]. Vis Neurosci, 2017, 34:E003[2017-06-20]. https://www.cambridge.org/core/journals/visual-neuroscience/article/intravitreallyadministered-dopamine-d2like-and-d4-but-not-d1like-receptor-agonists-reduce-formdeprivation-myopia-in-tree-shrews/48D706C13ED5DB116BA32E9646D9FCD3.DOI:10.1017/S0952523816000195.
[18] 赵娟, 刘兴党. 实验性近视眼视网膜多巴胺神经系统研究进展[J]. 国际放射医学核医学杂志, 2007, 31(2):73-76. DOI:10.3760/cma.j.issn.1673-4114.2007.02.004. Zhao J, Liu XD. Study and development of retinal dopamine nervous system in experimental myopia[J]. Int J Radiat Med Nucl Med, 2007, 31(2):73-76.
[19] Lacivita E, De Giorgio P, Lee IT, et al. Design, synthesis, radiolabeling, and in vivo evaluation of carbon-11 labeled N-[2-[4-(3-cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a potential positron emission tomography tracer for the dopamine D(4) receptors[J]. J Med Chem, 2010, 53(20):7344-7355. DOI:10.1021/jm100925m.
[20] 毛俊峰,刘双珍,秦文娟,等. 豚鼠形觉剥夺性近视眼视网膜,脉络膜多巴胺代谢的变化[J]. 中华眼视光学与视觉科学杂志, 2009, 11(1):33-37. DOI:10.3760/cma.j.issn.1674-845X.2009.01.010. Mao JF, Liu SZ, Qin WJ, et al. The change in dopamine metabolism in the retina and choroid of the Guinea pig with form-deprivation myopia[J]. Chin J Optom Ophthalmol Vis Sci, 2009, 11(1):33-37.
[21] Stone RA, Cohen Y, Mcglinn AM, et al. Development of experimental myopia in chicks in a natural environment[J]. Invest Ophthalmol Vis Sci, 2016, 57(11):4779-4789. DOI:10.1167/iovs.16-19310.
[22] Zhao J, Qu X, Qi Y, et al. Study on retinal dopamine transporter in form deprivation myopia using the radiopharmaceutical tracer 99mTc-TRODAT-1[J]. Nucl Med Commun, 2010, 31(10):910-915. DOI:10.1097/MNM.0b013e32833decc0.
[23] Tuerxun T, Numakawa T, Adachi N, et al. SA4503, a sigma-1 receptor agonist, prevents cultured cortical neurons from oxidative stressinduced cell death via suppression of MAPK pathway activation and glutamate receptor expression[J]. Neurosci Lett, 2010, 469(3):303-308. DOI:10.1016/j.neulet.2009.12.013.
[24] Chien CC, Pasternak GW. Selective antagonism of opioid analgesia by a sigma system[J]. J Pharmacol Exp Ther, 1994, 271(3):1583-1590.
[25] Ramakrishnan NK, Visser AK, Schepers M, et al. Dose-dependent sigma-1 receptor occupancy by donepezil in rat brain can be assessed with 11C-SA4503 and microPET[J]. Psychopharmacology(Berl), 2014, 231(20):3997-4006. DOI:10.1007/s00213-014-3533-2.
[26] Liu LL, Wang L, Zhong YM, et al. Expression of sigma receptor 1 mRNA and protein in rat retina[J]. Neuroscience, 2010, 167(4):1151-1159. DOI:10.1016/j.neuroscience.2010.03.006.
[27] Tagashira H, Zhang C, Lu YM, et al. Stimulation of sigma-1 receptor restores abnormal mitochondrial Ca2+ mobilization and ATP production following cardiac hypertrophy[J]. Biochim Biophys Acta, 2013, 1830(4):3082-3094. DOI:10.1016/j.bbagen.2012.12.029.
[28] Shimazawa M, Sugitani S, Inoue Y, et al. Effect of a sigma-1 receptor agonist, cutamesine dihydrochloride (SA4503), on photoreceptor cell death against light-induced damage[J]. Exp Eye Res, 2015, 132:64-72. DOI:10.1016/j.exer.2015.01.017.
[29] Vilner BJ, John CS, Bowen WD. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines[J]. Cancer Res, 1995, 55(2):408-413.
[30] Wang WF, Ishiwata K, Kiyosawa M, et al. Visualization of sigma1 receptors in eyes by ex vivo autoradiography and in vivo positron emission tomography[J]. Exp Eye Res, 2002,75(6):723-730.
[31] Bor-Seng-Shu E, Felicio AC, Braga-Neto P, et al. Dopamine transporter imaging using 99mTc-TRODAT-1 SPECT in Parkinson’s disease[J]. Med Sci Monit, 2014, 20:1413-1418. DOI:10.12659/MSM.890522.
[32] Shimizu S, Hirao K, Kanetaka H, et al. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer’s disease[J]. Eur J Nucl Med Mol Imaging, 2016, 43(1):184-192. DOI:10.1007/s00259-015-3146-y.
[33] Wu H, Lou C, Huang Z, et al. SPECT imaging of dopamine transporters with 99mTc-TRODAT-1 in major depression and Parkinson’s disease[J]. J Neuropsychiatry Clin Neurosci, 2011, 23(1):63-67. DOI:10.1176/jnp.23.1.jnp63.
[34] Yuan J, Liu XD, Han M, et al. Comparison of striatal dopamine transporter levels in chronic heroin-dependent and methamphetamine-dependent subjects[J]. Addict Biol, 2015, 22(1):229-234. DOI:10.1111/adb.12271.
[35] Yuan J, Lv R, Robert Bra?i? J, et al. Dopamine transporter dysfunction in Han Chinese people with chronic methamphetamine dependence after a short-term abstinence[J]. Psychiatry Res, 2014, 221(1):92-96. DOI:10.1016/j.pscychresns.2013.11.005.
[36] Liu Y, Han M, Liu X, et al. Dopamine transporter availability in heroin-dependent subjects and controls:longitudinal changes during abstinence and the effects of Jitai tablets treatment[J]. Psychopharmacology(Berl), 2013, 230(2):235-244. DOI:10.1007/s00213-013-3148-z.
[37] 席晓勍,褚仁远,周行涛,等. 实验性近视眼视网膜多巴胺转运蛋白研究[J]. 中华眼科杂志,2003,39(6):27-30. DOI:10.3760/j:issn:0412-4081.2003.06.007. Xi XQ, Chu RY, Zhou HT, et al. Studies of retinal dopamine transporter in experimental myopia[J]. Chin J Ophthalmol, 2003,39(6):27-30.
[38] 汪维芳,盛敏杰,林安娟,等. 正电子发射断层扫描术在兔眼神经受体成像的应用[J]. 眼科新进展,2009,29(7):514-518. Wang WF, Sheng MJ, Lin AJ, et al. Application of positron emission tomography for imaging of neuroreceptor in rabbit eyes[J]. Rec Adv Ophthal, 2009, 29(7):514-518.
[39] 汪维芳,盛敏杰,林安娟,等. 眼内σ1受体在PET中显像的实验研究[J]. 眼科, 2009, 18(3):198-203. Wang WF, Sheng MJ, Lin AJ, et al. Visualization of σ1 receptors in eyes by in vivo positron emission tomography and ex vivo autoradiography[J]. Ophthalmol Chn, 2009,18(3):198-203.
相似文献/References:
[1]梁雯丽,郑艳,李娜,等.Graves甲亢患者131I治疗后早期TRAb及TSAb变化的研究分析[J].国际放射医学核医学杂志,2016,40(1):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
Liang Wenli,Zheng Yan,Li Na,et al.Analysis of the changes in early TRAb and TSAb after 131I treatment for patients with Graves hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
[2]邢宇,赵新明.放射性核素标记HER2亲和体分子探针精准诊疗的研究进展[J].国际放射医学核医学杂志,2016,40(2):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
Xing Yu,Zhao Xinming.Advances in radionuclide-labeled HER2 affibody molecular probes for precise diagnosis and treatment[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
[3]郭坤,高蕊,于燕,等.表皮生长因子受体基因表达与甲状腺功能亢进症131I治疗预后的关系[J].国际放射医学核医学杂志,2015,39(1):4.[doi:10.3760/cma.j.issn.1673-4114.2015.01.003]
Guo Kun,Gao Rui,Yu Yan,et al.The relationship between epidermal growth factor receptor mRNA expression and the efficacv of 131I treatment in hyperthyroidism patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):4.[doi:10.3760/cma.j.issn.1673-4114.2015.01.003]
[4]杨洋,樊赛军.LXXLL模体在雌激素受体信号通路中的作用及应用价值[J].国际放射医学核医学杂志,2014,38(1):22.[doi:10.3760/cma.j.issn 1673-4114.2014.01.006]
Yang Yang,Fan Saijun.Role of LXXLL motif in modulation of estrogen receptor signaling and its potential application[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):22.[doi:10.3760/cma.j.issn 1673-4114.2014.01.006]
[5]白庆双,李宁,方佩华,等.人血清TRAb酶联免疫吸附试验检测在甲状腺疾病患者中的临床应用[J].国际放射医学核医学杂志,2014,38(2):80.[doi:10.3760/cma.j.issn.1673-4114.2014.02.003]
Bai Qingshuang,Li Ning,Fang Peihua,et al.The clinical application of human serum level of the TRAb measured by enzyme-linked immunosorbent assay in patients with thyroid diseases[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):80.[doi:10.3760/cma.j.issn.1673-4114.2014.02.003]
[6]李丽,赵长久,田国梅.CXC型趋化因子受体4及其分子显像剂在肿瘤方面的研究进展[J].国际放射医学核医学杂志,2014,38(3):190.[doi:10.3760/cma.j.issn.1673-4114.2014.03.012]
Li Li,Zhao Changjiu,Tian Guomei.Research progress of CXC chemokine receptor type 4 and molecular imaging in tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):190.[doi:10.3760/cma.j.issn.1673-4114.2014.03.012]
[7]周晓靓,王浩,施培基,等.表皮生长因子受体-酪氨酸激酶肿瘤分子显像剂的研究进展[J].国际放射医学核医学杂志,2013,37(2):100.[doi:10.3760/cma.j.issn.1673-4114.2013.02.010]
ZHOU Xiao-liang,WANG Hao,SHI Pei-ji,et al.The developme nt of epidermal growth factor receptor molecular imaging in cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):100.[doi:10.3760/cma.j.issn.1673-4114.2013.02.010]
[8]林美福,陈文新,周硕,等.18F-FES PET/CT显像在雌激素受体阳性乳腺癌诊疗中的初步应用[J].国际放射医学核医学杂志,2013,37(4):216.[doi:10.3760/cma.j.issn.1673-4114.2013.04.007]
LIN Mei-fu,CHEN Wen-xin,ZHOU Shuo,et al.Application of 18F-FES PET/CT in diagnosis and endocrine therapy of patients with estrogen receptorpositive breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):216.[doi:10.3760/cma.j.issn.1673-4114.2013.04.007]
[9]袁杰,刘兴党,韩梅.SPECT、PET神经受体和转运体显像技术在海洛因成瘾研究中的应用[J].国际放射医学核医学杂志,2013,37(1):30.[doi:10.3760/cma.j.issn.1673-4114.2013.01.009]
YUAN Jie,LIU Xing-dang,HAN Mei.Neuroreceptor and its transporters imaging by PET and SPECT in heroin addiction[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):30.[doi:10.3760/cma.j.issn.1673-4114.2013.01.009]
[10]鲍伟奇,邱春,管一晖.γ-氨基丁酸A型-苯二氮革受体显像剂在神经系统疾病中的应用[J].国际放射医学核医学杂志,2012,36(1):1.[doi:10.3760/cma.j.issn.1673-4114.2012.01.001]
BAO Wei-qi,QIU Chun,GUAN Yi-hui.Application of gamma-aminobutyric acid type A-benzodiazepine receptor imaging for study of neuropsychiatric disorders[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(5):1.[doi:10.3760/cma.j.issn.1673-4114.2012.01.001]
[11]赵娟,刘兴党.实验性近视眼视网膜多巴胺神经系统研究进展[J].国际放射医学核医学杂志,2007,31(2):73.
ZHAO Juan,LIU Xing-dang.Study and development of retinal dopamine nervous system in experimental myopia[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(5):73.